PRAXIS PRECISION MEDICINES, INC. Diluted Shares Outstanding (Weighted Average)
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Diluted Shares Outstanding (Weighted Average) of 29.13 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 29.13M shares, a 35.65% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 28.88M shares, a 37.18% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 25.50M shares, a 27.53% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 21.98M shares, a 16.38% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 22.50M shares, a 25.68% increase from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 17.91M shares, a 171.55% increase from fiscal 2023.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 6.59M shares, a 114.58% increase from fiscal 2022.
- PRAXIS PRECISION MEDICINES, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 3.07M shares, a 92.76% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 29.13M shares 10-Q · filed 2026-08-06 | 29.01M shares 10-Q · filed 2026-08-06 | 27.84M shares derived: average of 3 quarters · filed 2026-08-06 | 26.37M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 28.88M shares 10-Q · filed 2026-05-07 | 27.19M shares derived: average of 2 quarters · filed 2026-05-07 | 25.45M shares derived: average of 3 quarters · filed 2026-05-07 | 24.46M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 25.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 23.74M shares derived: average of 2 quarters · filed 2026-02-19 | 22.98M shares derived: average of 3 quarters · filed 2026-08-06 | 22.50M shares 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | 21.98M shares 10-Q · filed 2025-11-05 | 21.73M shares derived: average of 2 quarters · filed 2026-08-06 | 21.51M shares 10-Q · filed 2025-11-05 | 21.13M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 21.47M shares 10-Q · filed 2026-08-06 | 21.27M shares 10-Q · filed 2026-08-06 | 20.84M shares derived: average of 3 quarters · filed 2026-08-06 | 20.35M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 21.06M shares 10-Q · filed 2026-05-07 | 20.53M shares derived: average of 2 quarters · filed 2026-05-07 | 19.98M shares derived: average of 3 quarters · filed 2026-05-07 | 19.69M shares derived: average of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | 20.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 19.44M shares derived: average of 2 quarters · filed 2026-02-19 | 19.23M shares derived: average of 3 quarters · filed 2026-02-19 | 17.91M shares 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | 18.88M shares 10-Q · filed 2025-11-05 | 18.85M shares derived: average of 2 quarters · filed 2025-11-05 | 17.21M shares 10-Q · filed 2025-11-05 | 15.18M shares derived: average of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | 18.82M shares 10-Q · filed 2025-08-04 | 16.36M shares 10-Q · filed 2025-08-04 | 13.94M shares derived: average of 3 quarters · filed 2026-02-19 | 12.71M shares derived: average of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | 13.90M shares 10-Q · filed 2025-05-02 | 11.50M shares derived: average of 2 quarters · filed 2026-02-19 | 10.68M shares derived: average of 3 quarters · filed 2026-02-19 | 9.17M shares derived: average of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | 9.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 9.06M shares derived: average of 2 quarters · filed 2026-02-19 | 7.59M shares derived: average of 3 quarters · filed 2026-02-19 | 6.59M shares 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | 9.04M shares 10-Q · filed 2024-11-06 | 135.59M shares 10-Q · filed 2023-11-07 | 6.84M shares derived: average of 2 quarters · filed 2024-11-06 | 5.76M shares 10-Q · filed 2024-11-06 | 86.45M shares 10-Q · filed 2023-11-07 | -26.81M shares derived: average of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | 4.65M shares 10-Q · filed 2024-08-13 | 69.74M shares 10-Q · filed 2023-08-09 | 4.10M shares 10-Q · filed 2024-08-13 | 61.47M shares 10-Q · filed 2023-08-09 | -38.76M shares derived: average of 3 quarters · filed 2024-08-13 | -17.63M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 3.54M shares 10-Q · filed 2024-05-13 | 53.10M shares 10-Q · filed 2023-05-11 | -60.47M shares derived: average of 2 quarters · filed 2024-05-13 | -25.06M shares derived: average of 3 quarters · filed 2024-05-13 | -7.41M shares derived: average of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | -124.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -39.35M shares derived: average of 2 quarters · filed 2024-03-05 | -11.06M shares derived: average of 3 quarters · filed 2024-03-05 | 3.07M shares 10-K · filed 2024-03-05 | 46.10M shares 10-K · filed 2023-02-07 | |||
| 2022-09-30 | 45.77M shares 10-Q · filed 2023-11-07 | 45.66M shares derived: average of 2 quarters · filed 2023-11-07 | 45.59M shares 10-Q · filed 2023-11-07 | 45.44M shares derived: average of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | 45.54M shares 10-Q · filed 2023-08-09 | 45.50M shares 10-Q · filed 2023-08-09 | 45.33M shares derived: average of 3 quarters · filed 2023-08-09 | 45.18M shares derived: average of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | 45.46M shares 10-Q · filed 2023-05-11 | 45.22M shares derived: average of 2 quarters · filed 2023-05-11 | 45.05M shares derived: average of 3 quarters · filed 2023-05-11 | 44.18M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 44.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | 44.85M shares derived: average of 2 quarters · filed 2023-02-07 | 43.76M shares derived: average of 3 quarters · filed 2023-02-07 | 42.45M shares 10-K · filed 2023-02-07 | ||||
| 2021-09-30 | 44.71M shares 10-Q · filed 2022-11-09 | 43.14M shares derived: average of 2 quarters · filed 2022-11-09 | 41.61M shares 10-Q · filed 2022-11-09 | 38.90M shares derived: average of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | 41.57M shares 10-Q · filed 2022-08-08 | 40.03M shares 10-Q · filed 2022-08-08 | 36.97M shares derived: average of 3 quarters · filed 2022-08-08 | 28.14M shares derived: average of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | 38.47M shares 10-Q · filed 2022-05-09 | 34.67M shares derived: average of 2 quarters · filed 2022-05-09 | 23.67M shares derived: average of 3 quarters · filed 2022-05-09 | 18.16M shares derived: average of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | 30.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 16.26M shares derived: average of 2 quarters · filed 2022-02-28 | 11.39M shares derived: average of 3 quarters · filed 2022-02-28 | 8.95M shares 10-K · filed 2022-02-28 | ||||
| 2020-09-30 | 1.67M shares 10-Q · filed 2021-11-03 | 1.65M shares derived: average of 2 quarters · filed 2021-11-03 | 1.65M shares 10-Q · filed 2021-11-03 | |||||
| 2020-06-30 | 1.64M shares 10-Q · filed 2021-08-16 | 1.64M shares 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |